<DOC>
	<DOCNO>NCT00370396</DOCNO>
	<brief_summary>This study evaluate safety , reactogenicity immunogenicity booster dose GSK Biologicals ' pneumococcal conjugate vaccine compare Prevenar™ give 12-18 mo age child prim either pneumococcal vaccine Prevenar™ study 105553 . Antibody persistence evaluate 8-14 mo completion 3-dose immunization course study 105553 . The immune response booster dose GSK Biologicals ' pneumococcal conjugate vaccine also evaluate give 12-18 mo subject prim GSK Biologicals ' vaccine Prevenar™ . The study 3 group . 1 group child prim GSK Biologicals ' pneumococcal conjugate vaccine receive booster dose vaccine . 2nd group child prim Prevenar™ receive booster dose Prevenar™ ( control group ) . 3rd group child prim Prevenar™ receive booster dose GSK Biologicals ' pneumococcal conjugate vaccine . All child receive concomitantly booster dose DTPa-HBV-IPV/Hib vaccine .</brief_summary>
	<brief_title>Safety Immunogenicity Study Booster Dose GSK Biologicals ' 10-valent Pneumococcal Conjugate Vaccine .</brief_title>
	<detailed_description />
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>healthy male female , 12 18 month age time vaccination , receive least one dose either pneumococcal conjugate vaccine Prevenar™ study 105553 write informed consent obtain parent/guardian subject . use investigational nonregistered drug vaccine study vaccine within 30 day precede vaccination , plan use entire study period ( active phase safety followup ) . Planned administration/ administration vaccine foreseen study protocol period start one month vaccination Visit 2 . Administration additional pneumococcal vaccine DTPacombined vaccine since end study 105553 . Children history seizures neurological disease , allergic disease , immunosuppressive immunodeficient condition .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Streptococcus pneumonia , pneumococcal conjugate vaccine</keyword>
</DOC>